Vertex Pharmaceuticals (VRTX) ended the recent trading session ... Meanwhile, the Dow experienced a drop of 0.25%, and the technology-dominated Nasdaq saw an increase of 1.24%.

In trading on Thursday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) entered into oversold territory, hitting an RSI reading of 24.8, after changing hands as low as $377.85 per share.

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Low PE Investor model based on the ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two stocks is more ...

Fintel reports that on December 9, 2024, Jefferies upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from Hold to Buy. As of December 2, 2024, the average one-year price target for ...

Equities researchers at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals ...

Fintel reports that on December 9, 2024, Jefferies upgraded their outlook for Vertex Pharmaceuticals (WBAG:VRTX) from Hold to Buy. There are 2,805 funds or institutions reporting positions in ...

Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading ... Elsewhere, the Dow lost 0.35%, while the tech-heavy Nasdaq lost 0.25%. Shares of the drugmaker witnessed a loss of 5. ...

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...

It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have lost about 8.6% in that time frame, underperforming the S&P 500. Will the recent negative ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third ...